In-Person

 In-person • Oct 16–17, 2025 • Paris, France

An intermediate-level, case-studies-based course focuses on the current state and future potential of CAR-T cell therapies for autoimmune diseases. It addresses the challenges in developing CAR-T therapies, explores potential solutions, and provides an overview of the regulatory requirements and manufacturing processes critical for successful treatment.

Target Audience: Clinical researchers, clinicians, and physicians involved in CAR-T cell translation for clinical applications.

LEARN MORE →

 In-person • Oct 27–31, 2025 • Pennsylvania, Philadelphia, USA

An advanced course featuring expert-led lectures, dynamic discussions, and personalized mentoring sessions with global CGT thought leaders. Scholars will gain cutting-edge knowledge in key areas such as preclinical development, IND development, study design, cell manufacturing, QA, regulatory affairs, funding, and commercialization to advance their projects from bench to bedside.

Target Audience: Fellow-in-training or Junior Faculty members working in BMT and CGT fields with an active translational research project in cell, gene or tissue therapy readied for translation to the clinic.

LEARN MORE →